China New Product European Bilberry Extract Export to Ukraine

China New Product  European Bilberry Extract Export to Ukraine

Short Description:

A. Basic information Product name European Bilberry Extract Source of plant Vaccinium myrtillus Linn Active ingredient Anthocyans  compound Specification Total Anthocyanin 36%,total anthocyanidin 25% EP、USP Standard;  Instant(water); OEM accepted Solvent for extraction Water B. Main function a) Prevention of eye fatigue caused by screen viewing, relief fatigue and swelling in the legs b)Preventi...


Product Detail

Product Tags

, , ,
China New Product European Bilberry Extract Export to Ukraine Detail:

A. Basic information

Product name

European Bilberry Extract

Source of plant

Vaccinium myrtillus Linn

Active ingredient

Anthocyans  compound

Specification

Total Anthocyanin 36%total anthocyanidin 25%

EPUSP Standard 

Instantwater); OEM accepted

Solvent for extraction

Water

B. Main function

a) Prevention of eye fatigue caused by screen viewing, relief fatigue and swelling in the legs

b)Prevention of high blood pressure,anti-aging

C. Critical To Quality

Ø Finger-print identification      we.png

Ø Content of active substance 

Ø Control of solvent & pesticide residue

Ø Whole process in low-temperature

production

D. Quality control & Product Advantage   

Conforms to USP&EP standard

Derive from fine quality bilberry

QA&QC systemStrictly executing documented procedure prevention management, quality assured

Leading technology of separation and purification, the first to use freeze-drying technology

Technical advantageSharing of professional product identification techniques

Various specifications, OEM accepted

Instant product

E. Product specification

Content of active ingredient 

European Bilberry Extract

AnthocyanidinHPLC

Free anthocyanidin

HPLC

Anthocyanidin

 UV

EP 8.0

36%

1.0%

25%

OEM all specifications bilberry extract

       OEM Water-soluble & instant product

Item of test

Testing standard

Testing method

Character

Appearance

Purple-black powder

Sensory evaluation

Identification

Odor

With characteristic odor of bilberry

Sensory evaluation

Fingerprints

Conforms with standard

SW/T 2-2003

Examination

Particle size

98% pass through 80 mesh

CP2015<0982>

Loss on drying

NMT 5.0%

GB 5009.3

Ash content

NMT 3.0%

GB 5009.4

Bulk density

0.60~1.00g/mL

SW/T 2-2003

pH

3.0~4.5

SW/T 2-2003

Content

determination

Content of anthocyanin HPLC

NLT 36.0%

SW/T 2-2003

Limit of free anthocyanins HPLC

NMT 1.0%

Content of anthocyanin(in delphinidin)UV

NLT 25.0%

Solvent residues

Ethyl alcohol

NMT 1000mg/kg

SW/T 2-2003

Heavy metal

Heavy metal( Pb)

NMT 20.0mg/kg

GB/T 5009.74

Lead

NMT 3.0mg/kg

GB 5009.12

Arsenic

NMT 1.0mg/kg

CP2015<2321>

Mercury

NMT 0.1mg/kg

Cadmium

NMT 1.0mg/kg

GB/T 5009.15

Pesticide residues

666

NMT 0.05ppm

CP2015<2341>

DDT

NMT 0.05ppm

Microorganism

Total plant count

  NMT 1000CFU/g

GB 4789.2

Mould

NMT 50CFU/g

GB 4789.15

Yeast

NMT 50CFU/g

GB 4789.15

Escherichia coli

NMT 3MPN/g

GB 4789.3

Pathogenic bacteria(salmonella,shigella,staphylococcus aureus,streptococcus hemolyticus)

Not be detected

GB 4789.4/ 5/ 10/ 11

            


Product detail pictures:

China New Product  European Bilberry Extract Export to Ukraine detail pictures


China New Product European Bilberry Extract Export to Ukraine, The product will supply to all over the world, such as: , , ,



  • Elias Jabbour, MD from the University of Texas MD Anderson Cancer Center, Houston, TX talks about a Phase II clinical trial of inotuzumab ozogamicin in elderly acute lymphoblastic leukemia (ALL) patients, presented at the American Society of Hematology (ASH) 2015 Annual Meeting, Orlando, FL. Inotuzumab ozogamicin is an anti-CD22 antibody that contains a toxin attached to it, called calicheamicin. When the antibody binds to the cells, the toxin is internalized, binds to DNA, resulting in cell death. This drug was administered to relapsed/refractory patients, in combination with lower-dose chemotherapy (mini-hyper-CVD). The drug proved to be very effective, with a response rate of 95%, and all patients achieving minimum residual disease (MRD) negativity status. Dr Jabbour also discusses the side-effects observed in this study.
    Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, at Orlando, FL.

    Send your message to us:

    INQUIRY NOW
    • * CAPTCHA: Please select the Flag

    Related Products

    INQUIRY NOW
    • * CAPTCHA: Please select the Flag

    WhatsApp Online Chat !